111 related articles for article (PubMed ID: 14505954)
1. Botox: not just for faces. It's making headlines for smoothing frown lines, but Botox can also ease some hard-to-treat medical conditions.
Harv Womens Health Watch; 2003 Sep; 11(1):6-7. PubMed ID: 14505954
[No Abstract] [Full Text] [Related]
2. Botox. It's not just for wrinkles.
Mayo Clin Womens Healthsource; 2003 Nov; 7(11):1-2. PubMed ID: 14608225
[No Abstract] [Full Text] [Related]
3. More than skin deep. Botox applications go beyond frown lines.
Rollet J
Adv Nurse Pract; 2004 Dec; 12(12):33-4. PubMed ID: 15615218
[No Abstract] [Full Text] [Related]
4. Botox and Dysport are distinct.
Madaliński M
Endoscopy; 2000 Jun; 32(6):502-3. PubMed ID: 10863924
[No Abstract] [Full Text] [Related]
5. Botox injections may ease tension in women with pelvic muscle spasms.
Mayo Clin Womens Healthsource; 2007 Apr; 11(4):3. PubMed ID: 17351550
[No Abstract] [Full Text] [Related]
6. Botox approved for severe underarm sweating.
FDA Consum; 2004; 38(5):3. PubMed ID: 15595129
[No Abstract] [Full Text] [Related]
7. Botulinum toxin A for the treatment of chronic anal fissure.
Brisinda G; Cadeddu F; Mazzeo P; Maria G
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):219-28. PubMed ID: 19072412
[TBL] [Abstract][Full Text] [Related]
8. The treatment algorithm instead of the unknown optimal dose of botulinum toxin for chronic anal fissure.
Madalinski M
Aliment Pharmacol Ther; 2004 Jul; 20(1):125; author reply 125-7. PubMed ID: 15225181
[No Abstract] [Full Text] [Related]
9. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles.
Thomson AJ; Jarvis SK; Lenart M; Abbott JA; Vancaillie TG
BJOG; 2005 Feb; 112(2):247-9. PubMed ID: 15663593
[No Abstract] [Full Text] [Related]
10. BOTOX delivery by iontophoresis.
Kavanagh GM; Oh C; Shams K
Br J Dermatol; 2004 Nov; 151(5):1093-5. PubMed ID: 15541093
[TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs. Dysport" controlled trial.
Brisinda G; Albanese A; Cadeddu F; Bentivoglio AR; Mabisombi A; Marniga G; Maria G
Aliment Pharmacol Ther; 2004 Mar; 19(6):695-701. PubMed ID: 15023172
[TBL] [Abstract][Full Text] [Related]
12. Elastic net instead of ink to mark botox injection sites for frontal hyperhidrosis.
Al-Khenaizan S
J Drugs Dermatol; 2006; 5(10):1016. PubMed ID: 17373155
[No Abstract] [Full Text] [Related]
13. Botulinum toxin treatment for anal fissure.
Radwan MM; Ramdan K; Abu-Azab I; Abu-Zidan FM
Afr Health Sci; 2007 Mar; 7(1):14-7. PubMed ID: 17604520
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic anal fissure with botulinic toxin type A].
Charúa Guindic L; Fonseca Muñoz E; Guerra Melgar LR; Avendaño Espinosa O; García Pérez NJ; Charúa Levy E
Rev Gastroenterol Mex; 2007; 72(1):22-8. PubMed ID: 17685196
[TBL] [Abstract][Full Text] [Related]
15. Safety of botulinum neurotoxin treatment in patients with chronic anal fissure.
Brisinda D; Maria G; Fenici R; Civello IM; Brisinda G
Dis Colon Rectum; 2003 Mar; 46(3):419-20. PubMed ID: 12626924
[No Abstract] [Full Text] [Related]
16. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
Benohanian A
Br J Dermatol; 2005 Aug; 153(2):460-1; author reply 461. PubMed ID: 16086777
[No Abstract] [Full Text] [Related]
17. Botox for back pain and "regular" versus migraine headaches.
Fishman SM
J Pain Palliat Care Pharmacother; 2006; 20(2):37-40. PubMed ID: 16702136
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for hyperhidrosis: an important tool but not the ultimate cure.
Bechara FG; Sand M; Altmeyer P; Schmidt J
Dermatol Surg; 2008 Jun; 34(6):854-5; author reply 855-6. PubMed ID: 18363727
[No Abstract] [Full Text] [Related]
19. Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy.
Cohen JL; Cohen G; Solish N; Murray CA
Facial Plast Surg Clin North Am; 2007 Feb; 15(1):17-30, v-vi. PubMed ID: 17317552
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A by iontophoresis for primary palmar hyperhidrosis.
Kavanagh GM; Shams K
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S115-7. PubMed ID: 17052528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
